All Stories

  1. Staphylococcus aureus Infection in Humanized Mice: A New Model to Study Pathogenicity Associated With Human Immune Response

    Article • The Journal of Infectious Diseases, February 2015, Oxford University Press (OUP)

    Dr Nancie M Archin

  2. Broadly-specific Cytotoxic T Cells Targeting Multiple HIV Antigens Are Expanded From HIV+ Patients: Implications for Immunotherapy

    Article • February 2015, Elsevier

    Dr Nancie M Archin

  3. Expanded Cytotoxic T-cell Lymphocytes Target the Latent HIV Reservoir

    Article • The Journal of Infectious Diseases, January 2015, Oxford University Press (OUP)

    Dr Nancie M Archin

  4. Eradicating HIV-1 infection: seeking to clear a persistent pathogen

    Article • Nature Reviews Microbiology, October 2014, Springer Science + Business Media

    Dr Nancie M Archin

  5. Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4+ T Cells

    Article • Journal of Virology, September 2014, ASM Journals

    Dr Nancie M Archin

  6. Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection

    Article • PLoS ONE, August 2014, PLOS

    Dr Nancie M Archin

  7. HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat

    Article • The Journal of Infectious Diseases, March 2014, Oxford University Press (OUP)

    Dr Nancie M Archin

  8. Emerging strategies to deplete the HIV reservoir

    Article • Current Opinion in Infectious Diseases, February 2014, Wolters Kluwer Health

    Dr Nancie M Archin

  9. Targeted Cytotoxic Therapy Kills Persisting HIV Infected Cells During ART

    Article • PLoS Pathogens, January 2014, PLOS

    Dr Nancie M Archin

  10. HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice

    Article • Journal of Virology, January 2014, ASM Journals

    Dr joel blankson, Dr Nancie M Archin

  11. An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients

    Article • PLoS Pathogens, December 2013, PLOS

    Dr Nancie M Archin, Dr Eric Verdin

  12. HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model

    Article • Retrovirology, January 2013, Springer Science + Business Media

    Dr Nancie M Archin

  13. Reactivation of latent HIV-1 in central memory CD4+ T cells through TLR-1/2 stimulation

    Article • Retrovirology, January 2013, Springer Science + Business Media

    Dr Nancie M Archin, Dr Eric Verdin

  14. Erratum: Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

    Article • Nature, August 2012, Springer Science + Business Media

    Dr Nancie M Archin

  15. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1

    Article • Journal of Leukocyte Biology, July 2012, Society for Leukocyte Biology

    Dr Nancie M Archin

  16. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

    Article • Nature, July 2012, Springer Science + Business Media

    Dr Nancie M Archin

  17. Immediate antiviral therapy appears to restrict resting CD4 + cell HIV-1 infection without accelerating the decay of latent infection

    Article • Proceedings of the National Academy of Sciences, May 2012, Proceedings of the National Academy of Sciences

    Dr Nancie M Archin

  18. Latent HIV-1 Infection of Resting CD4+ T Cells in the Humanized Rag2-/-  c-/- Mouse

    Article • Journal of Virology, October 2011, ASM Journals

    Dr Nancie M Archin

  19. Generation of HIV Latency in Humanized BLT Mice

    Article • Journal of Virology, October 2011, ASM Journals

    Dr Nancie M Archin

  20. Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2

    Article • Journal of Virology, June 2011, ASM Journals

    Dr Nancie M Archin

  21. Clonal Sequences Recovered from Plasma from Patients with Residual HIV-1 Viremia and on Intensified Antiretroviral Therapy Are Identical to Replicating Viral RNAs Recovered from Circulating Resting CD4+ T Cells

    Article • Journal of Virology, March 2011, ASM Journals

    Dr Nancie M Archin

  22. Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection

    Article • PLoS ONE, February 2010, PLOS

    Professor John M Coffin, Dr Nancie M Archin

  23. Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors

    Article • AIDS, September 2009, Wolters Kluwer Health

    Dr Nancie M Archin

  24. A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression

    Article • Journal of Virology, March 2009, ASM Journals

    Dr Nancie M Archin

  25. Pharmaceutical approaches to eradication of persistent HIV infection

    Article • Expert Reviews in Molecular Medicine, February 2009, Cambridge University Press

    Dr Nancie M Archin

  26. Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid

    Article • AIDS Research and Human Retroviruses, February 2009, Mary Ann Liebert Inc

    Dr Nancie M Archin

  27. Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells

    Article • AIDS, June 2008, Wolters Kluwer Health

    Professor John M Coffin, Dr Nancie M Archin

  28. Hexamethylbisacetamide and Disruption of Human Immunodeficiency Virus Type 1 Latency in CD4 + T Cells

    Article • The Journal of Infectious Diseases, April 2008, Oxford University Press (OUP)

    Dr Nancie M Archin

  29. Eliminating Persistent HIV Infection: Getting to the End of the Rainbow

    Article • The Journal of Infectious Diseases, June 2007, Oxford University Press (OUP)

    Dr Nancie M Archin

  30. Attacking HIV Provirus: Therapeutic Strategies to Disrupt Persistent Infection

    Article • Infectious Disorders - Drug Targets, December 2006, Bentham Science Publishers

    Dr Nancie M Archin

  31. Hexamethylbisacetamide Remodels the Human Immunodeficiency Virus Type 1 (HIV-1) Promoter and Induces Tat-Independent HIV-1 Expression but Blunts Cell Activation

    Article • Journal of Virology, May 2006, ASM Journals

    Dr Nancie M Archin

  32. Coaxing HIV-1 from resting CD4 T cells

    Article • AIDS, May 2004, Wolters Kluwer Health

    Dr Nancie M Archin

  33. Delayed Spread and Reduction in Virus Titer after Anterior Chamber Inoculation of a Recombinant of HSV-1 Expressing IL-16

    Article • Investigative Ophthalmology & Visual Science, July 2003, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Nancie M Archin

  34. Infiltration of T-lymphocytes in the brain after anterior chamber inoculation of a neurovirulent and neuroinvasive strain of HSV-1

    Article • Journal of Neuroimmunology, September 2002, Elsevier

    Dr Nancie M Archin

  35. Rapid spread of a neurovirulent strain of HSV-1 through the CNS of BALB/c mice following anterior chamber inoculation

    Article • Journal of NeuroVirology, January 2002, Springer Science + Business Media

    Dr Nancie M Archin

  36. Posterior cortical atrophy in Alzheimer's disease: analysis of a new case and re-evaluation of a historical report

    Article • Acta Neuropathologica, August 1993, Springer Science + Business Media

    Dr Nancie M Archin

  37. DISTRIBUTION OF GLUTAMATE RECEPTOR SUBUNIT PROTEINS IN MONKEY NEOCORTEX

    Article • Journal of Neuropathology & Experimental Neurology, May 1993, Oxford University Press (OUP)

    Dr Nancie M Archin

  38. The primary auditory cortex in cetacean and human brain: A comparative analysis of neurofilament protein-containing pyramidal neurons

    Article • Neuroscience Letters, October 1992, Elsevier

    Dr Nancie M Archin